InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Gassert Chad, SVP, Développement Corporatif et Stratégie. Director active across 1 company, notably ANI Pharmaceuticals INC. In total, 3 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €122k. Activity tracked since 18 March 2022. The latest transaction was disclosed on 18 March 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations3 total
5,000 shares@ US$27.14880.0069% mcap100.0% of flowCommon StockSEC:0001415889-22-003267:0
Ideal exit: 13 Dec 2022 (T+270)
383,226 sharesCommon StockSEC:0001415889-21-005442
383,226 sharesCommon StockSEC:0001415889-21-005442:0
3 of 3 declarations
About Gassert Chad
Chad Gassert is the SVP of Corp. Dev. & Strategy at ANI PHARMACEUTICALS INC. He is responsible for developing and implementing the company's growth strategies. His role is essential in identifying new market opportunities and strengthening the company's competitive position. He works closely with management to align strategic initiatives with the company's overall goals.
